Sponsor

University Of Antwerp

Belgium Drie Eikenstraat 663, 2650 Edegem, Belgium

About the sponsor

COVID-19 and avian influenza research are central to the sponsor’s infectious disease portfolio, with a strong emphasis on innate immunity, humoral immune responses, and cell-mediated immunity after vaccination. The funded studies also include pertussis vaccination in pregnancy and zoonotic influenza, reflecting interest in immune protection across different populations and viral threats.

COVID-19 mRNA vaccination
Zoonotic influenza immunogenicity
Pertussis vaccination in pregnancy
Innate and adaptive immune responses

Several projects focus on how vaccination shapes immune activity in healthy adults and pregnant women, with attention to antibody responses and immune priming.

About Specializations

University Of Antwerp runs clinical trials in conditions such as Papilloma viral infection, Muscle spasticity, Major depression, Plasma cell myeloma, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Quick filters

7 clinical trials

Papilloma viral infection

Recruiting

Registered drugNo placebo

Study of HPV antibody response in urine samples before and after HPV 9-valent vaccine in people with Human Papillomavirus infection

Registered drugNo placebo

Belgium

Participants:18–64 years
Substances:Human Papillomavirus Type 11 L1 Protein - Adsorbed - In The Form Of Virus-Like Particles Produced In Yeast Cells (Saccharomyces Cerevisiae Canade 3C-5 (Strain 1895)) By Rdna
Sponsor:University Of Antwerp